Novaccess Global Inc XSNX

Healthcare Biotechnology

NovAccess Global Inc. is a biopharmaceutical company, which develops immunotherapies to treat brain tumor patients in the United States. The Company specializes in research related to utilizing a patient’s own immune system to attack the cancer. Its dendritic cell-based immunotherapy utilizes a combination of Toll-like receptor adjuvants for an enhanced antitumor response. The therapy is designed to utilize the patient’s tumor antigens and immune cells, dendritic cells, in combination with TLR adjuvants to initiate an efficient antitumor immune response. This process includes obtaining the patients' tumor cells after surgery, and precursors cells that are matured into dendritic cells from peripheral blood. Its TLR-AD1 platform technology is a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high-grade gliomas. TLR-AD1 technology has a scope of use and is embodied in various different product lines for different clinical situations.

OTCPK:XSNX - Post by User

Novaccess Global Inc > NEWS: Trump Supports States Rights for Cannabis Regulation -

<< Previous

Bullboard Posts

Next >>

Comment by mramon Apr 13, 2018 3:11pm

69 Views

Post# 27881892

RE:NEWS: Trump Supports States Rights for Cannabis Regulation -

should give the most warranted BOOST to XSUNX share price.....
Solar Panels for California MJ Grow UPS ==== Business Growth...

mram wrote:

https://www.newcannabisventures.com/breaking-news-trump-supports-states-rights-for-cannabis-laws/

BREAKING NEWS: Trump Supports States Rights for Cannabis Regulation

April 13, 2018 at 1:55 pm

Exclusive article by Alan Brochstein, CFA

Facebook Twitter LinkedIn Reddit Google+

The Washington Post has broken news that could be the most important political change for the cannabis industry to date, suggesting that Senator Cory Gardner (R: CO) has struck a deal with President Trump regarding the rights of states to regulate cannabis. While there is no final deal, the Senator, who has been blocking Department of Justice nominations, suggest that his discussions with other senators will yield a bill that would permanently address the issue of federal enforcement.

President Trump has promised a top Senate Republican that he will support congressional efforts to protect states that have legalized marijuana — defusing a months-long standoff between Sen. Cory Gardner and the administration over Justice Department nominees.

While progress across the country has been substantial for the industry, the uncertainty at the federal level, with Jeff Sessions rescinding the Cole Memo earlier this year, has been a substantial overhang. Cannabis stocks are rallying sharply on this developing story.

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email